Jiaxing Xie1, Nazanin Zounemat Kermani1,2, Stelios Pavlidis1,2, Kai Sun2, Yike Guo2, Richard G Knowles3, Qingling Zhang4, Sven-Erik Dahlen5, Peter Sterk6, Ratko Djukanovic7 , Kian Fan Chung1,2, Ian M. Adcock1,2 on behalf of the U-BIOPRED study group#
1National Heart and Lung Institute, Imperial College London, and Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, UK; 2Dept of Computing and Data Science Institute, Imperial College London, London, UK;3Knowles Consulting, Stevenage Bioscience Catalyst, Stevenage, UK; 4Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health & The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China;5Centre for Allergy Research, Karolinska Institute, Stockholm, Sweden; 6Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands;7NIHR Southampton Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK .
#The list of U-BIOPRED study group members is provided in an online supplementary Table.